Research Led Product Advancements and Innovations to Drive the Global Market Growth

Global clot management devices market is anticipated to grow at a CAGR of 7.3% during the forecast period (2024-2031). Clot management devices have a wide range of applications in various medical conditions. They are used in the management of pulmonary embolism, ischemic stroke, peripheral artery disease, coronary artery disease, venous thromboembolism prophylaxis, and peripheral vascular interventions. These devices play a crucial role in restoring blood flow, removing clots, and improving overall patient outcomes. Furthermore, the market has seen significant growth primarily owing to increased focus on R&D by both public and private organizations and growing applications. For instance,

Browse the full report description of “Clot Management Devices Market Size, Share & Trends Analysis Report by Products (Embolectomy Balloon Catheter, Catheter Directed Thrombolysis Devices, Percutaneous Thrombectomy Devices, Inferior Vena Cava Filters, Neurovascular Embolectomy Devices, and Others), and by End-User (Ambulatory Surgical Centers (ASCs), Diagnostic Centers, and Others) Forecast Period (2024-2031)” at https://www.omrglobal.com/industry-reports/clot-management-devices-market

In January 2023, Penumbra launched new mechanical thrombectomy system, known as Lightning Flash, which helps remove large blood clots in the body, including venous thrombus and pulmonary emboli (PE).

In June 2023,Inari Medical launched two new catheters for thrombectomy. The two products are such as,Triever16 Curve catheter and the RevCore thrombectomy catheter. Part of the FlowTriever platform, the Triever16  Curve catheter is designed for use in both peripheral thrombectomy and pulmonary embolism procedures.

In September 2020, Royal Philips launched of the QuickClear mechanical thrombectomy system. The single-use system delivers an all-in-one aspiration pump and catheter to remove blood clots from the vessels of the peripheral arterial and venous systems.The system’s design aimed to simplify the use of the device and improve procedure times without the need for capital equipment or accessories.

Market Coverage

• The market number available for – 2023-2031

• Base year- 2023

• Forecast period- 2024-2031

• Segment Covered- 

o By Product

o By End-User

• Regions Covered-

o North America

o Europe

o Asia-Pacific

o Rest of the World

• Competitive Landscape- Boston Scientific Corp.,Edwards Lifesciences Corp.,Medtronic PLC,Penumbra, Inc.,Teleflex Inc., and others.

Key questions addressed by the report.

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Clot Management Devices Market Report Segment

By Product

• Embolectomy Balloon Catheter
• Catheter Directed Thrombolysis Devices
• Percutaneous Thrombectomy Devices
• Inferior Vena cava Filters
• Neurovascular Embolectomy Devices
• Others(Permanent, Retrievable, and Neurovascular Embolectomy Devices)

By End-User

• Hospitals and Clinics
• Ambulatory Surgical Centers (ASCs)
• Diagnostic Centers
• Others(Research and Academic Institutions, and Home Healthcare Settings)

Global Clot Management Devices Market Report Segment by Region

North America

• United States

• Canada 

Europe

• UK

• Germany

• Italy

• Spain

• France

• Rest of Europe 

Asia-Pacific

• China

• India

• Japan

• South Korea

• Rest of Asia-Pacific 

Rest of the World

• Latin America 

• Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/clot-management-devices-market